5-Caffeoylquinic acid decreases diet-induced obesity in rats by modulating PPARα and LXRα transcription

Journal of the Science of Food and Agriculture

Volumn 95, Issue 9, 2015, Pages 1903-1910

  Huang, Kang ^a   Liang, Xiu ci ^a   Zhong, Ying li ^a   He, Wan yan ^a   Wang, Zheng ^a  

^a HUNAN AGRICULTURAL UNIVERSITY   (China)

Author keywords

5 CQA; CGA; Lipid metabolism; LXR ; Obesity; PPAR

Indexed keywords

RATTUS;

5'-O-CAFFEOYLQUINIC ACID; ANTILIPEMIC AGENT; ANTIOBESITY AGENT; ANTIOXIDANT; CHLOROGENIC ACID; FATTY ACID; LIPID; LIVER X RECEPTOR; ORPHAN NUCLEAR RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; QUINIC ACID;

ADVERSE EFFECTS; AGONISTS; ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD; COMPARATIVE STUDY; DIETARY SUPPLEMENT; GENE EXPRESSION REGULATION; GENETICS; HYPERLIPIDEMIAS; LIPID DIET; LIPID METABOLISM; LIVER; MALE; METABOLISM; OBESITY; PATHOLOGY; RANDOMIZATION; SPRAGUE DAWLEY RAT;

ADIPOSITY; ANIMALS; ANTI-OBESITY AGENTS; ANTIOXIDANTS; CHLOROGENIC ACID; DIET, HIGH-FAT; DIETARY SUPPLEMENTS; FATTY ACIDS, NONESTERIFIED; GENE EXPRESSION REGULATION; HYPERLIPIDEMIAS; HYPOLIPIDEMIC AGENTS; LIPID METABOLISM; LIPIDS; LIVER; MALE; OBESITY; ORPHAN NUCLEAR RECEPTORS; PPAR ALPHA; QUINIC ACID; RANDOM ALLOCATION; RATS, SPRAGUE-DAWLEY;

EID: 84930684312     PISSN: 00225142     EISSN: 10970010     Source Type: Journal    
DOI: 10.1002/jsfa.6896     Document Type: Article

References (53)

1. Lodhi Irfan J, Yin L, Jensen-Urstad APL, Funai K, Coleman T, Baird JH, et al., Inhibiting adipose tissue lipogenesis reprograms thermogenesis and PPARγ activation to decrease diet-induced obesity. Cell Metab 16:189-201 (2012).
2. Bener A, Yousafzai MT, Darwish S, Al-Hamaq AOAA, Nasralla EA and Abdul-Ghani M, Obesity index that better predict metabolic syndrome: body mass index, waist circumference, waist hip ratio, or waist height ratio. J Obesity 2013:9 (2013).
3. Ohnaka K, Ikeda M, Maki T, Okada T, Shimazoe T, Adachi M, et al., Effects of 16-week consumption of caffeinated and decaffeinated instant coffee on glucose metabolism in a randomized controlled trial. J Nutr Metab 2012:9 (2012).
4. Lingxiao Gong, Lingyun Gong and Ying Zhang, Intake of Tibetan hull-less barley is associated with a reduced risk of metabolic related syndrome in rats fed high-fat-sucrose diets. Nutrients 6:1635-1648 (2014).
5. Panchal SK and Brown L, Rodent models for metabolic syndrome research. J Biomed Biotechnol 2011:14 (2011).
6. Popkin BM, Adair LS, and Shu Wen Ng, Now and then: The global nutrition transition: The pandemic of obesity in developing countries. Nutr Rev 70:3-21(2012).
7. Kastorini CM, Milionis HJ, Ioannidi A, Kalantzi K, Nikolaou, Vemmos KN, et al. Adherence to the Mediterranean diet in relation to acute coronary syndrome or stroke nonfatal events: A comparative analysis of a case/case-control study. Am Heart J 162:717-724 (2011).
8. Hanhineva K, Törrönen R, Bondia-Pons I, Pekkinen J, Kolehmainen M, Mykkänen H, et al., Impact of dietary polyphenols on carbohydrate metabolism. Int J Mol Sci 11:1365-1402 (2010).
9. Wang Z, Clifford MN and Sharp P, Analysis of chlorogenic acids in beverages prepared from Chinese health foods and investigation, in vitro, of effects on glucose absorption in cultured Caco-2 cells. Food Chem 108:369-373 (2008).
10. Marques V and Farah A, Chlorogenic acids and related compounds in medicinal plants and infusions. Food Chem 113:1370-1376 (2009).
11. Kasai H, Fukada S, Yamaizumi Z, Sugie S and Mori H, Action of chlorogenic acid in vegetables and fruits as an inhibitor of 8-hydroxydeoxyguanosine formation in vitro and in a rat carcinogenesis model. Food Chem Toxicol 38:467-471 (2000).
12. Rosengren A, Dotevall A, Wilhelmsen L, Thelle D and Johansson S, Coffee and incidence of diabetes in Swedish women: A prospective 18-year follow-up study. J Intern Med 255:89-95 (2004).
13. Narita Y and Inouye K, Kinetic analysis and mechanism on the inhibition of chlorogenic acid and its components against porcine pancreas α-amylase isozymes I and II. J Agric Food Chem 57:9218-9225 (2009).
14. +-dependent D-glucose uptake in rat intestinal brush border membrane vesicles. J Nutr 119:1698-1704 (1989).
15. Bassoli BK, Cassolla P, Borba-Murad GR, Constantin J, Salgueiro-Pagadigorria CL, Bazotte RB, et al., Chlorogenic acid reduces the plasma glucose peak in the oral glucose tolerance test: effects on hepatic glucose release and glycaemia. Cell Biochem Funct 26:320-328 (2008).
16. McCarty MF, A chlorogenic acid-induced increase in GLP-1 production may mediate the impact of heavy coffee consumption on diabetes risk. Med Hypotheses 64:848-853 (2005).
17. Ong KW, Hsu A and Tan BKH, Chlorogenic acid stimulates glucose transport in skeletal muscle via AMPK activation: a contributor to the beneficial effects of coffee on diabetes. PLoS One 7:11 (2012).
18. Li S-Y, Chang C-Q, Ma F-Y and Yu C-L, Modulating effects of chlorogenic acid on lipids and glucose metabolism and expression of hepatic peroxisome proliferator-activated receptor-α in golden hamsters fed on high fat diet. Biomed Environ Sci 22:122-129 (2009).
19. Cho A-S, Jeon S-M, Kim M-J, Yeo J, Seo K-I, Choi M-S, et al., Chlorogenic acid exhibits anti-obesity property and improves lipid metabolism in high-fat diet-induced-obese mice. Food Chem Toxicol 48:937-943 (2010).
20. Rodriguez de Sotillo DV and Hadley M, Chlorogenic acid modifies plasma and liver concentrations of: cholesterol, triacylglycerol, and minerals in (fa/fa) Zucker rats. J Nutr Biochem 13:717-726 (2002).
21. Shimoda H, Seki E and Aitani M, Inhibitory effect of green coffee bean extract on fat accumulation and body weight gain in mice. BMC Complem Altern M DOI:10.1186/472-6882-6-9 (2006)
22. Kwok Cheong JD, Croft KD, Henry PD, Mattews V, Hodgson JM and Ward NC, Green coffee polyphenols not attenuate features of the metabolic syndrome and improve endothelial function in mice fed a high fat diet. Arch Biochem Biophys 559:46-52 (2014).
23. Mubarak A, Hodgson JM, Considine MJ, Croft KD and Matthews VB, Supplementation of a high fat diet with chlorogenic acid is associated with insulin resistance and hepatic lipid accumulation in mice. J Agric Food Chem 61:4371-4378 (2013).
24. Panchal SK, Poudyal H, Waanders J and Brown L, Coffee extract attenuates changes in cardiovascular and hepatic structure and function without decreasing obesity in high-carbohydrate, high-fat diet-fed male rats. J Nutr 24:690-697(2012).
25. Nicholls SJ and Uno K, Peroxisome proliferator-activated receptor (PPARα/γ) agonists as a potential target to reduce cardiovascular risk in diabetes. Diabetes Vasc Dis Re 9:89-94 (2012).
26. Peet DJ, Turley SD, Ma W, Janowski BA, Lobaccaro J-MA, Hammer RE, et al., Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXRα. Cell 93:693-704 (1998).
27. Yue L, Ye F, Gui C, Luo H, Cai J, Shen J, et al., Ligand-binding regulation of LXR/RXR and LXR/PPAR heterodimerizations: SPR technology-based kinetic analysis correlated with molecular dynamics simulation. Protein Sci 14:812-822 (2005).
28. Yoshikawa T, Ide T, Shimano H, Yahagi N, Amemiya-Kudo M, Matsuzaka T, et al., Cross-talk between peroxisome proliferator-activated receptor (PPAR) α and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. I. PPARs suppress sterol regulatory element binding protein promoter through inhibition of LXR signaling. Mol Endocrinol 17:1240-1254 (2003).
29. Repa JJ, Liang G, Ou J, Bashmakov Y, Lobaccaro J-MA, Shimomura I, et al., Regulation of mouse sterol regulatory element-binding protein gene (SREBP) by oxysterol receptors, LXRα and LXRβ. Gene Dev 14:2819-2830 (2000).
30. Joseph SB, Laffitte BA, Patel PH, Watson MA, Matsukuma KE, Walczak R, et al., Direct and indirect mechanisms for regulation of fatty acid synthase gene expression by liver X receptors. J Biol Chem 277:11019-11025 (2002).
31. Talukdar S and Hillgartner FB, The mechanism mediating the activation of acetyl-coenzyme A carboxylase-α gene transcription by the liver X receptor agonist T0-901317. J Lipid Res 47:2451-2461 (2006).
32. Boergesen M, Pedersen TÅ, Gross B, van Heeringen SJ, Hagenbeek D, Bindesbøll C, et al., Genome-wide profiling of liver X receptor, retinoid X receptor, and peroxisome proliferator-activated receptor α in mouse liver reveals extensive sharing of binding sites. Mol Cell Biol 32:852-867 (2012).
33. Ebbert JO and Jensen MD, Fat depots, free fatty acids, and dyslipidemia. Nutrients 5:498-508 (2013).
34. IUPAC C and CBN II, The nomenclature of cyclitols. Eur J Biochem 5:1-12 (1968).
35. Huang J, Huang X, Chen Z, Cheng Q and Sun R, Dose conversion of different animals and healthy volunteers in a pharmacologic study. Chin J Clin Pharmacol Ther 9:1069-1072 (2004). (in Chinese)
36. Karthikesan K, Pari L and Menon VP, Antihyperlipidemic effect of chlorogenic acid and tetrahydrocurcumin in rats subjected to diabetogenic agents. Chem Biol Interact 188:643-650 (2010).
37. Gutschi LM, Malcolm JC, Favreau CM and Ooi TC, Paradoxically decreased HDL-cholesterol levels associated with rosiglitazone therapy. Ann Pharmacother 40:1672-1676 (2006).
38. Crook MA, Lynas J, and Wray R, A paradoxical severe decrease in serum HDL-cholesterol after treatment with a fibrate. J Clin Pathol 53:796-797 (2000).
39. Berge R, Tronstad K, Berge K, Rost T, Wergedahl H, Gudbrandsen O, et al., The metabolic syndrome and the hepatic fatty acid drainage hypothesis. Biochimie 87:15-20 (2005).
40. Attar BM and Van Thiel DH, Current concepts and management approaches in nonalcoholic fatty liver disease. Sci World J 2013:10 (2013).
41. Wen-Yuan Du, Cheng Chang, Yu Zhang, Yu-Ying Liu, Kai Sun, Chuan-She Wang, et al., High-dose chlorogenic acid induces inflammation reactions and oxidative stress injury in rats without implication of mast cell degranulation. J Ethnopharmacol 147:74-83 (2013).
42. Kim S, Shin H-J, Kim SY, Kim JH, Lee YS, Kim D-H, et al., Genistein enhances expression of genes involved in fatty acid catabolism through activation of PPARα. Mol Cell Endocrinol 220:51-58 (2004).
43. Cho KW, Kim YO, Andrade JE, Burgess JR and Kim Y-C, Dietary naringenin increases hepatic peroxisome proliferators-activated receptor α protein expression and decreases plasma triglyceride and adiposity in rats. Eur J Nutr 50:81-88 (2011).
44. Guerre-Millo M, Gervois P, Raspé E, Madsen L, Poulain P, Derudas B, et al., Peroxisome proliferator-activated receptor α activators improve insulin sensitivity and reduce adiposity. J Biol Chem 275:16638-16642 (2000).
45. Zhang Y, Repa JJ, Gauthier K and Mangelsdorf DJ, Regulation of lipoprotein lipase by the oxysterol receptors, LXRα and LXRβ. J Biol Chem 276:43018-43024 (2001).
46. Ravikumar B, Carey PE, Snaar JE, Deelchand DK, Cook DB, Neely RD, et al., Real-time assessment of postprandial fat storage in liver and skeletal muscle in health and type 2 diabetes. Am J Physiol Endocrinol Metab 288:789-797 (2005).
47. Koonen DP, Jacobs RL, Febbraio M, Young ME, Soltys CL, Ong H, et al., Increased hepatic CD36 expression contributes to dyslipidemia associated with diet-induced obesity. Diabetes 56:2863-2871 (2007).
48. Makowski L, Boord JB, Maeda K, Babaev VR, Uysal KT, Morgan MA, et al., Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis. Nat Med 7:699-705 (2001).
49. Uysal KT, Scheja L, Wiesbrock SM, Bonner-Weir S and Hotamisligil GS, Improved glucose and lipid metabolism in genetically obese mice lacking aP2. Endocrinology 141:3388-3396 (2000).
50. Schultz JR, Tu H, Luk A, Repa JJ, Medina JC, Li L, et al., Role of LXRs in control of lipogenesis. Gene Dev 14:2831-2838 (2000).
51. Cha J-Y and Repa JJ, The liver X receptor (LXR) and hepatic lipogenesis. The carbohydrate-response element-binding protein is a target gene of LXR. J Biol Chem 282:743-751 (2007).
52. Kampe K, Sieber J, Orellana JM, Mundel P and Jehle AW, Susceptibility of podocytes to palmitic acid is regulated by fatty acid oxidation and inversely depends on acetyl-CoA carboxylases 1 and 2. Am J Physiol Renal Physiol 306:401-409 (2014).
53. Wakil SJ and Abu-Elheiga LA, Fatty acid metabolism: Target for metabolic syndrome. J Lipid Res 50:138-143 (2009).